Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job Description The Laboratory Chemicals Division (LCD) provides a full range of analytical reagents and research and discovery chemicals to Thermo Fisher’s core markets worldwide. LCD has been identified as a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)